Home > Insider Trading > Filing (0001209191-13-038370)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1344413	Alexza Pharmaceuticals Inc.	ALXA	Pharmaceutical Preparations (2834)	770567768

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1279309	Braxton Thomas King	Alexza Pharmaceuticals Inc. 2091 Stierlin Court Mountain View CA 94043	Pres & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-07-24	25,000	$4.48	200,000	No	4	P	Direct
Common Stock	Acquisiton	2013-07-25	12,580	$4.50	212,580	No	4	P	Direct
Common Stock	Acquisiton	2013-07-26	2,420	$4.49	215,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	30,823	Indirect	By The Thomas B. and Beth King 2000 Family Trust, as co-trustee

Footnotes

All of the shares were purchased within a price range between $4.43 to $4.50 per share, with a weighted average price per share of $4.476. Upon request, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
All of the shares were purchased within a price range between $4.47 to $4.50 per share, with a weighted average price per share of $4.498. Upon request, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
Includes 175,000 previously reported shares issued as restricted stock units ("RSUs") under the Issuer's 2005 Equity Incentive Plan (the "Plan"). If the Issuer's common stock listed on the Nasdaq Global Market has traded at or above $8.63 on each trading day of any 30-day trading period after March 29, 2013 (the "Price Trigger"), then 50% of the RSUs will vest on the later of March 29, 2016 and the date on which the Price Trigger is met, and the remaining 50% of the RSUs will vest on the later of March 29, 2017 and the date on which the Price Trigger is met, provided in each case that the Reporting Person remains employed by the Company through the applicable vesting date.
This Report is being filed solely to correct the foregoing footnotes to reflect the purchase vs. sale of shares reported therein.